Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 05-03-2024 | Mental Health in Older People | Case Report

Suspected geriatric onset of attention-deficit/hyperactivity disorder in a patient with comorbid bipolar disorder

Authors: Joshua Woods, Nakisa Kiai, Ranjit Padhy, Rossano Bangasan, Tyler Torrico

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

An increasing number of adults over 60 years old are presenting with requests for treatment of attention-deficit/hyperactivity disorder (ADHD). However, the prevalence of ADHD in older adults in geriatrics is unknown. Further, comorbid bipolar disorder and adult ADHD are likely underrecognized with many patients only receiving treatment for one of these conditions. The occurrence of bipolar disorder with geriatric onset ADHD is unknown.

Case presentation

A 64-year-old Hispanic woman with a psychiatric history of bipolar I disorder (diagnosed in early adulthood) was diagnosed with ADHD suspected of geriatric onset, and able to be successfully managed on concurrent mood stabilizers and psychostimulant medication.

Conclusions

The findings of this case report emphasize the importance of appropriately recognizing and treating comorbid ADHD and bipolar disorder in any age group, including the geriatric population for which this occurrence appears to be very rare. Additionally, this case report demonstrates the safe utilization of psychostimulant medications in a geriatric patient with bipolar disorder without inducing a manic episode or other significant adverse reactions.
Literature
3.
go back to reference Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–23.CrossRefPubMedPubMedCentral Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–23.CrossRefPubMedPubMedCentral
4.
go back to reference Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med. 2005;35(6):817–27.CrossRefPubMed Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med. 2005;35(6):817–27.CrossRefPubMed
5.
go back to reference Schiweck C, Arteaga-Henriquez G, Aichholzer M, Edwin Thanarajah S, Vargas-Cáceres S, Matura S, Grimm O, Haavik J, Kittel-Schneider S, Ramos-Quiroga JA, Faraone SV, Reif A. Comorbidity of ADHD and adult bipolar disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;124:100–23. Epub 2021 Jan 27. PMID: 33515607.CrossRefPubMed Schiweck C, Arteaga-Henriquez G, Aichholzer M, Edwin Thanarajah S, Vargas-Cáceres S, Matura S, Grimm O, Haavik J, Kittel-Schneider S, Ramos-Quiroga JA, Faraone SV, Reif A. Comorbidity of ADHD and adult bipolar disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;124:100–23. Epub 2021 Jan 27. PMID: 33515607.CrossRefPubMed
8.
go back to reference Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D, ADMET 2 Research Group. Effect of methylphenidate on apathy in patients with Alzheimer Disease: the ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021;78(11):1324–32. https://doi.org/10.1001/jamaneurol.2021.3356. PMID: 34570180; PMCID: PMC8477302.CrossRefPubMed Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D, ADMET 2 Research Group. Effect of methylphenidate on apathy in patients with Alzheimer Disease: the ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021;78(11):1324–32. https://​doi.​org/​10.​1001/​jamaneurol.​2021.​3356. PMID: 34570180; PMCID: PMC8477302.CrossRefPubMed
11.
go back to reference Pary R, Scarff JR, Jijakli A, Tobias C, Lippmann S. A Review of Psychostimulants for Adults With Depression. Fed Pract. 2015;32(Suppl 3):30S-37S. PMID: 30766117. Pary R, Scarff JR, Jijakli A, Tobias C, Lippmann S. A Review of Psychostimulants for Adults With Depression. Fed Pract. 2015;32(Suppl 3):30S-37S. PMID: 30766117.
Metadata
Title
Suspected geriatric onset of attention-deficit/hyperactivity disorder in a patient with comorbid bipolar disorder
Authors
Joshua Woods
Nakisa Kiai
Ranjit Padhy
Rossano Bangasan
Tyler Torrico
Publication date
05-03-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04852-2

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine